| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 23.825 | 44.407 | 53.008 | 58.336 | 57.121 | 60.867 | 78.906 | 94.780 |
| Total Income - EUR | - | - | 23.825 | 44.579 | 53.008 | 58.337 | 57.121 | 60.868 | 78.907 | 94.780 |
| Total Expenses - EUR | - | - | 17.982 | 22.733 | 22.611 | 26.205 | 25.385 | 24.601 | 28.630 | 32.753 |
| Gross Profit/Loss - EUR | - | - | 5.843 | 21.846 | 30.397 | 32.132 | 31.736 | 36.267 | 50.278 | 62.027 |
| Net Profit/Loss - EUR | - | - | 5.634 | 21.400 | 29.867 | 31.571 | 31.165 | 35.658 | 49.489 | 59.184 |
| Employees | - | - | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Medfam Dr Bobancu Diana Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 7.256 | 6.969 | 6.642 | 6.253 | 6.081 | 5.871 | 5.649 |
| Current Assets | - | - | 8.175 | 24.426 | 24.289 | 26.142 | 28.990 | 36.798 | 46.280 | 63.441 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.783 | 3.682 | 8.391 | 13.234 | 4.971 | 22.130 | 37.465 | 57.614 |
| Cash | - | - | 5.392 | 20.744 | 15.899 | 12.907 | 24.019 | 14.668 | 8.814 | 5.827 |
| Shareholders Funds | - | - | 5.678 | 26.974 | 29.917 | 31.621 | 34.133 | 41.508 | 50.438 | 59.232 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.497 | 4.707 | 1.341 | 1.163 | 1.110 | 1.371 | 1.713 | 9.858 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medfam Dr Bobancu Diana Srl